An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Hypermagnesemia
Severe magnesium excess can progress from weakness and bradycardia to respiratory failure, heart block, and cardiac arrest. Renal impairment plus magnesium-containing laxatives or antacids is a common setup.
Also known asmagnesium toxicity · hypermag · magnesium overdose
A 72-year-old woman with chronic kidney disease has been unusually hard to wake since breakfast. Her daughter says she has been taking several over-the-counter products for constipation; the room smells faintly of mint. On the monitor, her pulse is 44, and her breathing is shallow. The first laboratory results are arriving, but the team has not yet decided what to do.
— What’s your move? Read on.
Before you read
What is the immediate treatment when magnesium is suppressing cardiac or neuromuscular function?
When is dialysis the definitive move?
When to Think of It
Consider it with unexplained lethargy, weakness, diminished or absent reflexes, hypotension, bradycardia, PR/QRS prolongation, or respiratory depression—especially with renal failure, magnesium-containing products, or obstetric magnesium therapy. Check serum magnesium, renal function, calcium, and ECG; a medication and supplement history is essential.
Sick or Not Sick
The key fork is symptomatic cardiac, respiratory, or neuromuscular toxicity versus an elevated level without end-organ effects. Respiratory depression, hemodynamic instability, significant conduction changes, or rapidly rising levels call for immediate resuscitation and consideration of dialysis.
The First Fifteen Minutes
Stop all magnesium sources; place on continuous ECG and pulse-oximetry monitoring, establish IV access, and support airway/ventilation as needed.
If hypotension, bradycardia, conduction abnormality, or neuromuscular/respiratory toxicity: calcium gluconate 1 g IV (10 mL of 10% solution) over 5–10 minutes; repeat if toxicity persists, because calcium temporarily antagonizes magnesium’s effects at excitable tissues.
If severe toxicity with peri-arrest physiology and reliable central access: calcium chloride 1 g IV (10 mL of 10% solution); it delivers more elemental calcium than gluconate, so avoid extravasation.
If volume replete, making urine, and renal function permits: furosemide 20–40 mg IV, because increased urinary flow can enhance magnesium excretion; avoid this strategy in anuric renal failure or volume depletion.
Call nephrology early for severe toxicity or impaired renal clearance; do not wait for a magnesium level to normalize before treating clinical instability.
Definitive Care & Disposition
Discontinue magnesium sources and treat contributing renal dysfunction. Hemodialysis is the most reliable removal strategy for severe symptoms, substantial renal impairment, or persistent toxicity; consider ICU care for respiratory compromise, shock, or significant dysrhythmia. In mild, asymptomatic elevation with preserved renal function, observation and repeat levels may be appropriate.
How This One Kills
Treating the laboratory number rather than the patient—or relying on diuresis in an anuric patient—can allow progressive respiratory and cardiac depression while definitive clearance is delayed.
The Differential — What Else Looks Like This
Opioid toxicity — pinpoint pupils and a compatible exposure may help; confusing it delays recognition of a correctable electrolyte cause of bradycardia and areflexia.
Guillain–Barré syndrome — progressive weakness with preserved or brisk reflexes early is more typical; attributing acute areflexia to neuropathy can miss a reversible toxidrome.
Hyperkalemia — potassium-related ECG changes and weakness can overlap; confusing them risks giving the wrong targeted therapy.
The Second-Day Story
Older adults may present only with falls, confusion, weakness, or poor oral intake; classic areflexia may be undocumented, and patients may not consider laxatives or antacids to be medications. In renal impairment, ask specifically about magnesium-containing products and check magnesium when unexplained bradycardia, hypotension, or diminished reflexes accompany the vague presentation.
Back to Our Patient
Back to our 72-year-old with shallow breathing and a pulse of 44: the supplement history and diminished reflexes make magnesium toxicity a priority while the team checks ECG, magnesium, renal function, and competing causes. Her ECG shows PR prolongation, and the magnesium level is markedly elevated in the setting of renal failure. Recognize the symptomatic toxicity, risk-stratify her as unstable, give calcium gluconate 1 g IV with ECG reassessment, support ventilation, and involve nephrology urgently for dialysis; she goes to the ICU for definitive clearance and monitoring.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 72-year-old woman with chronic kidney disease presenting with acute lethargy, shallow breathing, and bradycardia. Her daughter reports recent use of multiple over-the-counter constipation products, and the patient is difficult to arouse. She is hypotensive with a pulse of 44, diminished deep-tendon reflexes, and shallow respirations; ECG shows PR prolongation without a wide QRS. Initial testing shows markedly elevated serum magnesium and impaired renal function. I’m concerned for symptomatic magnesium toxicity with cardiac and respiratory depression; I’ve stopped magnesium sources, started monitoring and respiratory support, and am giving IV calcium with immediate repeat ECG assessment. She needs ICU care and urgent nephrology consultation for dialysis because her renal clearance is poor and she is clinically unstable.”
Study Directive
From memory, list the cardiac, respiratory, and reflex findings that signal clinically significant magnesium toxicity.
Practice a 30-second medication history that specifically screens for magnesium products.
Review your local dialysis-consult triggers for toxic electrolyte disturbances and recite when diuresis is inappropriate.
A focused reference for recognizing magnesium toxicity and treating symptomatic hypermagnesemia with IV calcium, magnesium elimination, and dialysis when needed.
Hoca E, Arat EK, Arat O, et al. · Ir J Med Sci, 2024 · PMID 37684491 · cited 4×
Hypermagnesemia is associated with worse hospital outcomes, so an elevated level should prompt assessment for toxicity and impaired renal clearance rather than dismissal as an incidental finding.
More in Today's Issue
3 additional topics
2 of 4
Hypomagnesemia
Magnesium depletion can provoke seizures and dangerous dysrhythmias and can make hypokalemia and hypocalcemia difficult to correct. The low serum value may...
Also known aslow magnesium · magnesium deficiency · hypoMg
A 58-year-old man with a long history of heavy alcohol use is brought in after a brief convulsion at home. His hands tremble as he wakes, and the cardiac monitor shows an irregular rhythm. He has had little to eat for several days, and the first set of electrolytes is still pending.
Before You Read
Which rhythm or neurologic findings make magnesium replacement urgent?
What other electrolyte abnormalities should you look for before assuming replacement is complete?
When is IV replacement preferable to oral therapy?
Why It Matters
Magnesium depletion can provoke seizures and dangerous dysrhythmias and can make hypokalemia and hypocalcemia difficult to correct. The low serum value may be only part of the deficit.
When to Think of It
Consider it with seizures, tremor, tetany, prolonged QT, ventricular dysrhythmia, refractory hypokalemia or hypocalcemia, malnutrition, alcohol use disorder, gastrointestinal losses, or medications that increase renal wasting. Obtain magnesium, potassium, calcium, renal function, and ECG.
Sick or Not Sick
The decision that matters most is symptomatic or electrically unstable versus mild and asymptomatic. Seizure, torsades, ventricular dysrhythmia, or severe neuromuscular symptoms require monitored IV replacement; a stable patient who can absorb medication may be treated orally.
The First Fifteen Minutes
Place symptomatic patients on cardiac monitoring; check glucose, ECG, magnesium, potassium, calcium, and renal function. Treat active seizure or unstable rhythm while replacing magnesium.
If torsades or another life-threatening ventricular dysrhythmia is present: magnesium sulfate 2 g IV over 10–15 minutes; in cardiac arrest, give 1–2 g IV/IO, because magnesium can suppress early afterdepolarizations that sustain torsades.
If severe symptomatic deficiency without torsades: magnesium sulfate 1–2 g IV over 15–60 minutes, because IV replacement rapidly restores extracellular magnesium while symptoms are active; use slower administration if hemodynamics are tenuous.
If mild and asymptomatic with reliable absorption: oral magnesium oxide 400 mg PO, with ongoing replacement planned; oral therapy is slower and may cause diarrhea.
Adjust replacement for renal impairment and recheck levels; avoid reflexively giving repeated large doses to patients who cannot excrete magnesium.
Definitive Care & Disposition
Replete the deficit beyond initial symptom control, guided by repeat magnesium, renal function, symptoms, and ongoing losses. Correct associated potassium or calcium abnormalities, identify the cause, and review relevant medications. Admit for seizure, dysrhythmia, severe deficiency, ongoing losses, or need for IV replacement/monitoring; stable mild cases may be managed with oral replacement and follow-up.
How This One Kills
Replacing potassium or calcium without recognizing magnesium depletion can produce refractory abnormalities and recurrent dysrhythmia; an initial improvement does not prove the total-body deficit is corrected.
The Atypical Presentation
Older adults and patients with chronic malnutrition may have only weakness, falls, confusion, or palpitations; tremor and tetany can be subtle, and a single serum magnesium value does not fully reflect intracellular stores. Think of magnesium depletion when potassium or calcium remains low despite replacement, especially with poor nutrition, alcohol use, diarrhea, or relevant drug exposure.
Back to Our Patient
Back to our 58-year-old with tremor and a convulsion: the combination of poor intake, alcohol use, and an irregular rhythm warrants immediate ECG and electrolyte assessment. His ECG shows prolonged QT with a self-terminating episode of polymorphic ventricular tachycardia; magnesium is low, with concurrent hypokalemia. Recognize symptomatic deficiency with electrical instability, give magnesium sulfate 2 g IV over 10–15 minutes while monitoring, then replete magnesium and potassium with renal-function-guided repeat testing. He is admitted to a monitored setting for continued correction and evaluation of the cause.
Patient Presentation to Attending
“This is a 58-year-old man with heavy alcohol use presenting after a brief convulsion, with tremor and an irregular rhythm. He has eaten very little for several days and is now awake but tremulous. ECG shows a prolonged QT with a self-terminating episode of polymorphic ventricular tachycardia; labs show hypomagnesemia and hypokalemia. I’m concerned that symptomatic magnesium depletion is driving his electrical instability, with concurrent potassium depletion. I’m giving IV magnesium under cardiac monitoring, checking renal function and associated electrolytes, and will replete potassium as indicated. He needs monitored admission for continued replacement and evaluation of ongoing nutritional or gastrointestinal losses.”
Study Directive
Write the IV magnesium dose and infusion time for torsades and for severe symptomatic deficiency from memory.
Practice a differential for refractory hypokalemia that includes magnesium depletion.
Review how renal impairment changes the safety of repeat magnesium dosing.
Key Medications
Magnesium sulfate for torsades: 2 g IV over 10–15 minutes; during cardiac arrest, 1–2 g IV/IO.
Magnesium sulfate for severe symptomatic deficiency: 1–2 g IV over 15–60 minutes; further repletion is often needed and should be guided by repeat levels, kidney function, and local protocol.
Oral magnesium oxide: 400 mg PO; dosing and salt choice vary, and diarrhea may limit treatment.
Dose and infusion rate vary with severity and renal function; check Lexicomp, UpToDate, or institutional protocol when uncertain. Pediatric dosing is weight-based and differs from adult dosing.
High-Yield Pearls
Persistent hypokalemia despite adequate potassium replacement should prompt a magnesium check.
Serum magnesium can underestimate total-body depletion; treat the clinical context and follow the response, not just one result.
The Mimics
Alcohol withdrawal — a compatible timeline and autonomic hyperactivity may dominate; missing coexisting magnesium depletion leaves seizure and arrhythmia risk untreated.
Hypocalcemia — perioral numbness and tetany overlap; confusing the two can delay the electrolyte-specific correction.
Primary long-QT syndrome — a persistent or familial pattern favors an inherited disorder; attributing torsades solely to low magnesium can miss the underlying substrate.
Board Question
A patient with alcohol use disorder has torsades de pointes and a low serum magnesium concentration. Which treatment is most appropriate immediately?
AMagnesium sulfate 2 g IV
BOral magnesium oxide
CCalcium gluconate 1 g IV
DPotassium chloride 40 mEq PO
Reveal answer
Correct: A
IV magnesium is the immediate treatment for torsades, including when the serum magnesium value is not yet available. Oral replacement is too slow for an unstable ventricular rhythm.
Use this focused review to identify causes of hypomagnesemia and guide magnesium replacement, especially when hypokalemia or hypocalcemia persists despite treatment.
Hyperkalemia can progress to fatal conduction failure with little warning, and the ECG is an imperfect screen. The first actions protect the myocardium and...
Also known ashigh potassium · elevated serum potassium · hyperpotassemia · HyperK
A 67-year-old man arrives after missing his scheduled dialysis session. He says his legs feel heavy, and his fingertips tingle as he grips the bedrail. The monitor alarms; the ECG has changed since the tracing in his clinic chart. The bedside team is deciding what to do before the laboratory confirmation returns.
Before You Read
Which ECG or clinical findings require immediate cardiac stabilization?
What does membrane stabilization accomplish—and what does it not accomplish?
Which therapies shift potassium into cells, and how quickly must you recheck?
Why It Matters
Hyperkalemia can progress to fatal conduction failure with little warning, and the ECG is an imperfect screen. The first actions protect the myocardium and temporarily lower extracellular potassium; they do not remove potassium from the body.
When to Think of It
Suspect it with renal failure or missed dialysis, weakness or paralysis, potassium-raising drugs, acidosis, tissue breakdown, or a hemolyzed specimen that conflicts with the clinical picture. Obtain an ECG and potassium promptly, but treat immediately when ECG changes or instability suggest dangerous hyperkalemia.
Sick or Not Sick
The critical fork is electrical instability or concerning ECG changes versus no evidence of immediate cardiac toxicity. Do not wait for a particular potassium threshold if the ECG is concerning; a normal ECG does not rule out clinically significant hyperkalemia.
The First Fifteen Minutes
Cardiac monitor, IV access, 12-lead ECG, point-of-care glucose, and rapid potassium/renal-function testing; repeat a possibly hemolyzed sample if the patient is stable and the ECG is reassuring.
If ECG changes, dysrhythmia, or peri-arrest instability suggest hyperkalemia: calcium gluconate 1 g IV (10 mL of 10% solution) over 2–5 minutes; repeat in 5–10 minutes if changes persist, because calcium stabilizes the cardiac membrane but does not lower potassium.
If severe ECG changes with peri-arrest physiology and central access is available: calcium chloride 1 g IV (10 mL of 10% solution); it provides more elemental calcium but can cause serious tissue injury if extravasated.
If confirmed or strongly suspected dangerous hyperkalemia: regular insulin 10 units IV with dextrose 25 g IV (50 mL of D50), because insulin rapidly shifts potassium intracellularly; check glucose and monitor for delayed hypoglycemia.
If additional rapid shifting is needed and the patient can tolerate it: albuterol 10–20 mg nebulized, because beta-2 stimulation shifts potassium into cells; it is an adjunct, not a substitute for calcium or definitive removal.
If significant metabolic acidosis is present: sodium bicarbonate 50 mEq IV, because correcting substantial acidemia may promote intracellular potassium shift; it is not reliable as routine monotherapy.
Definitive Care & Disposition
Repeat potassium and glucose after temporizing therapy, commonly within 1–2 hours, and arrange potassium removal; these interventions wear off and rebound is possible. Patients with significant ECG changes, severe hyperkalemia, renal failure, or need for urgent dialysis require admission and early nephrology involvement. See Hyperkalemia Part 2 for removal strategies and rebound prevention.
How This One Kills
Treating the ECG with calcium and assuming the problem is solved leaves the potassium burden untouched; as the calcium effect fades, conduction toxicity can return.
The Atypical Presentation
Some patients—especially those with chronic kidney disease—have few symptoms despite dangerous potassium elevation, and classic peaked T waves may be absent. Weakness, bradycardia, or nonspecific ECG changes may be the only warning; use the clinical context and measured potassium, not a reassuring ECG alone.
Back to Our Patient
Back to our 67-year-old with heavy legs and tingling: missed dialysis makes hyperkalemia likely, and the changed ECG makes this an immediate cardiac-risk presentation. His ECG shows peaked T waves with QRS widening, and the point-of-care potassium is 7.1 mmol/L. Recognize dangerous hyperkalemia, risk-stratify him as electrically unstable, give IV calcium and shifting therapy with glucose monitoring, then arrange urgent dialysis for potassium removal. He is admitted for monitored care and definitive treatment.
Patient Presentation to Attending
“This is a 67-year-old man with end-stage kidney disease on hemodialysis, presenting with leg heaviness after missing his scheduled session. He reports fingertip tingling and has no chest pain or syncope. ECG shows peaked T waves and QRS widening; point-of-care potassium is 7.1 mmol/L. I’m concerned for severe hyperkalemia with ECG toxicity, not pseudohyperkalemia given the compatible presentation and tracing. I’ve placed him on continuous monitoring, given IV calcium and insulin with dextrose, and am checking glucose and repeat potassium. He needs urgent nephrology involvement and monitored admission for dialysis because intracellular shifting is temporary.”
Study Directive
Draw the sequence “stabilize, shift, remove” from memory and name one intervention in each category.
Practice identifying hyperkalemic ECG changes on three tracings and state when you would repeat calcium.
Review your ED’s post-insulin glucose-monitoring protocol.
Key Medications
Calcium gluconate: 1 g IV (10 mL of 10% solution) over 2–5 minutes; repeat in 5–10 minutes if ECG abnormalities persist.
Calcium chloride: 1 g IV (10 mL of 10% solution), preferably central, for severe instability/peri-arrest.
Regular insulin: 10 units IV with dextrose 25 g IV (50 mL D50); monitor glucose closely and provide further dextrose based on glucose and protocol.
Albuterol: 10–20 mg nebulized as an adjunct.
Sodium bicarbonate: 50 mEq IV when significant metabolic acidosis is present; benefit is variable outside that setting.
Insulin dose strategies vary in high-risk patients; check institutional protocol if uncertain. Pediatric treatment is weight-based and should follow a pediatric emergency protocol.
High-Yield Pearls
A normal ECG does not exclude severe hyperkalemia; clinical context and potassium measurement remain essential.
Insulin-related hypoglycemia can be delayed—plan glucose monitoring after administration rather than checking only once.
The Mimics
Pseudohyperkalemia — hemolysis, fist clenching, or marked thrombocytosis/leukocytosis can falsely elevate potassium; treating a spurious result risks iatrogenic hypokalemia.
Hypocalcemia — QT prolongation is more typical than the progressive QRS widening of severe hyperkalemia; confusing them can delay the appropriate cause-specific treatment.
Sodium-channel blocker toxicity — a compatible exposure and QRS widening may favor poisoning; misattribution can delay toxin-specific management.
Board Question
A patient with renal failure has potassium 7.0 mmol/L, peaked T waves, and QRS widening. After giving IV calcium, what is the best description of its effect?
AIt rapidly removes potassium through the kidneys.
BIt shifts potassium into cells.
CIt stabilizes the cardiac membrane without lowering serum potassium.
DIt prevents rebound hyperkalemia for 24 hours.
Reveal answer
Correct: C
IV calcium reduces the immediate risk of hyperkalemic dysrhythmia by stabilizing the cardiac membrane. Insulin and beta-agonists shift potassium intracellularly; definitive removal is still required.
AI-enabled ECG alerts may help flag dangerous potassium abnormalities and prompt timely treatment, but serum potassium testing remains essential for confirmation.
Shifting potassium into cells is temporary; without elimination, hyperkalemia can recur as treatment wears off. Delayed definitive removal is a major cause...
Also known ashigh potassium · elevated serum potassium · hyperpotassemia · HyperK
A 63-year-old woman with advanced kidney disease has just finished treatment for a high potassium result. Her hand tremor has eased, but the repeat bedside test is still abnormal, and she has produced only a small amount of urine all day. A dialysis nurse asks whether the team wants to prepare a session now. The decision is whether the improvement on the monitor is enough.
Before You Read
Which therapies actually remove potassium from the body?
When should you pursue urgent dialysis rather than another temporizing dose?
How do you prevent and detect rebound after shifting therapy?
Why It Matters
Shifting potassium into cells is temporary; without elimination, hyperkalemia can recur as treatment wears off. Delayed definitive removal is a major cause of rebound and repeat cardiac toxicity.
When to Think of It
Reassess after temporizing therapy with repeat potassium, ECG, glucose, urine output, renal function, acid-base status, and volume status. Think about ongoing potassium release or impaired excretion when levels remain high or rebound.
Sick or Not Sick
The key call is whether the patient can excrete potassium safely or needs urgent extracorporeal removal. Refractory or recurrent severe hyperkalemia, ECG toxicity, anuria/advanced renal failure, or a dialysis-related emergency warrants urgent nephrology involvement and dialysis planning.
The First Fifteen Minutes
Confirm the potassium trend with a nonhemolyzed specimen when feasible; repeat ECG and glucose after shifting therapy. Review medications, supplements, potassium intake, urine output, and possible tissue breakdown.
If ECG toxicity is present or recurs: calcium gluconate 1 g IV (10 mL of 10% solution) over 2–5 minutes; repeat in 5–10 minutes if changes persist, because calcium protects the myocardium but does not remove potassium.
If severe hyperkalemia persists or rebounds while definitive removal is being arranged: regular insulin 10 units IV with dextrose 25 g IV (50 mL D50), because insulin temporarily shifts potassium into cells; monitor glucose closely for delayed hypoglycemia.
If the patient is volume replete with usable renal function and needs enhanced urinary excretion: furosemide 20–40 mg IV, because loop diuresis increases urinary potassium loss; it is not effective in anuria and should not delay dialysis.
If the patient can take oral therapy and potassium removal is being arranged: sodium zirconium cyclosilicate 10 g PO three times daily for up to 48 hours, because it binds potassium in the gut; it is not a substitute for immediate stabilization or urgent dialysis.
Definitive Care & Disposition
Hemodialysis is the most reliable rapid removal strategy in severe hyperkalemia with renal failure, anuria, or inadequate response to other measures. For selected patients with urine output and appropriate volume status, diuresis may assist removal. Potassium binders can be adjuncts, but their onset and effectiveness vary; do not use them as the sole rescue treatment for ECG toxicity. Admit patients with severe, recurrent, or unexplained hyperkalemia; reassess potassium after treatment and arrange follow-up for medication changes and the underlying cause.
How This One Kills
Declaring victory because the ECG improved after insulin ignores the potassium still in the body; when the intracellular shift reverses, the potassium can rise again—often after the patient appears better.
The Atypical Presentation
Patients with chronic renal failure may feel better after shifting therapy even while potassium remains dangerously high or is beginning to rebound. In older adults, the only clues may be reduced urine output, missed dialysis, or an unexpectedly high repeat result; follow serial potassium, ECG, glucose, and urine output rather than symptom improvement alone.
Back to Our Patient
Back to our 63-year-old with little urine output and persistent potassium elevation after initial treatment: transient symptom improvement does not mean her potassium burden is gone. Her repeat potassium is 6.8 mmol/L after shifting therapy, and she remains oliguric with advanced kidney disease. Recognize persistent hyperkalemia, risk-stratify her as unable to excrete potassium safely, monitor ECG and glucose, and involve nephrology immediately for urgent dialysis; she is admitted for definitive removal and serial reassessment.
Patient Presentation to Attending
“This is a 63-year-old woman with advanced kidney disease presenting with severe hyperkalemia that persists after initial temporizing therapy. Her tremor has improved, but she has produced very little urine today. Repeat potassium is 6.8 mmol/L after treatment, and her ECG currently shows no new conduction changes. I’m concerned that intracellular shifting has not removed her total potassium burden and that rebound is likely because she is oliguric. I’m continuing cardiac and glucose monitoring, confirming the potassium trend, and have contacted nephrology for urgent dialysis. She needs monitored admission for definitive removal and repeat potassium assessment.”
Study Directive
From memory, sort hyperkalemia treatments into “stabilize,” “shift,” and “remove,” and state one limitation of each.
Review your hospital’s urgent-dialysis escalation criteria and identify whom to call after hours.
Practice interpreting a serial potassium/glucose timeline after insulin to recognize inadequate response, hypoglycemia, and rebound.
Key Medications
Calcium gluconate for recurrent ECG toxicity: 1 g IV (10 mL of 10% solution) over 2–5 minutes; repeat in 5–10 minutes if changes persist.
Regular insulin with dextrose for persistent/recurrent severe hyperkalemia: 10 units IV plus dextrose 25 g IV (50 mL D50); monitor glucose closely. Dose strategies vary in patients at high risk of hypoglycemia; use institutional protocol if uncertain.
Furosemide: 20–40 mg IV if volume status and renal function permit; dose may need adjustment for prior loop-diuretic use.
Sodium zirconium cyclosilicate: 10 g PO three times daily for up to 48 hours for potassium removal as an adjunct; not emergency monotherapy.
Patiromer: 8.4 g PO once daily is a chronic/adjunct option, not a rescue treatment for ECG toxicity; onset is not suitable for immediate stabilization.
Pediatric treatment is weight-based and differs from adult regimens; use a pediatric emergency protocol.
High-Yield Pearls
A persistently high potassium after an intracellular shift is a removal problem, not a reason to keep repeating calcium.
Potassium binders may support removal planning, but none replaces urgent stabilization and dialysis when severe toxicity and anuria demand it.
The Mimics
Pseudohyperkalemia — a hemolyzed specimen or marked thrombocytosis/leukocytosis can mislead; unnecessary treatment can cause dangerous hypokalemia.
Ongoing tissue breakdown — rhabdomyolysis or tumor lysis can keep releasing potassium; treating only renal clearance without addressing the source risks persistent rebound.
Adrenal insufficiency — hypotension and hyponatremia alongside hyperkalemia may point to deficient mineralocorticoid effect; missing it leaves the cause untreated.
Board Question
A patient with anuria and severe hyperkalemia improves after insulin and dextrose. Two hours later, the potassium remains markedly elevated. Which intervention provides the most reliable definitive removal?
ARepeat IV calcium alone
BUrgent hemodialysis
CNebulized albuterol alone
DOral patiromer as the only treatment
Reveal answer
Correct: B
Insulin and albuterol shift potassium into cells but do not remove it; in anuric renal failure, hemodialysis is the most reliable definitive removal. Calcium protects the myocardium but also does not lower potassium.
Tests whether AI-generated ECG alerts prompt faster recognition and treatment of potassium abnormalities, a potential aid when hyperkalemia is not yet confirmed by laboratory results.
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
A 24-year-old man presents after a self-terminating episode of palpitations, now asymptomatic with normal vitals. His resting 12-lead is unusual: the PR interval is strikingly short, under 120 ms, and the initial upstroke of each QRS is not sharp but slurred, rising slowly before… What’s the diagnosis, and the first move?
Check your answer
Pre-excitation Syndromes (WPW). Identify the accessory pathway on the resting tracing so that, if this patient returns in a tachyarrhythmia, you are prepared — pre-excited atrial fibrillation and AVRT change management, and AV-nodal blockers can be dangerous in pre-excited AF; arrange cardiology/electrophysiology follow-up for a symptomatic patient.
From the October 1 edition
Today, three days ago: Amiodarone. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
VF/pulseless VT: 300 mg IV/IO bolus, then 150 mg if needed. Stable VT: 150 mg IV over 10 min, may repeat, then infusion 1 mg/min x 6 h then 0.5 mg/min. Cardiogenic shock, severe sinus-node dysfunction, 2nd/3rd degree AV block without pacer, iodine hypersensitivity is debated but label caution applies.
From the September 24 edition
A dialysis patient with potassium 7.1 mEq/L has peaked T waves and a widening QRS. Which intervention most rapidly reduces immediate risk of dysrhythmia? -
ANebulized albuterol -
BIV calcium gluconate -
CIV regular insulin with dextrose -
DOral sodium zirconium cyclosilicate
Reveal answer
Correct · B
IV calcium stabilizes the myocardial membrane rapidly but does not lower serum potassium. Insulin and albuterol shift potassium intracellularly; dialysis removes it.
Journal Watch
From the FOAMed wire
Notable posts and reviews from the last week, ranked by relevance to today’s lead and source trust.
An 81-year-old male presents with a heart rate of 31 and a blood pressure of 81/47. He reports feeling lightheaded and chest pain. He recently had a pacemaker placed for having a “slow heart rate” but is unsure of information beyond that. On exam, there is no pacemaker noted...
Podcast Picks
Two for the shift
Critical Care Perspectives in Emergency Medicine2026-09-01
Brain damage and death from ischemic encephalopathy is common after cardiac arrest. Animal studies and limited observational studies suggest that high oxygen exposure after ROSC may result in neuronal death. As such, it is hypothesized that limiting oxygen exposure (conservative oxygen) many attenuate reperfusion injury and improve outcomes. At present,...
Source
Critical Care Perspectives in Emergency Medicine
Published
2026-09-01
Host
Critical Care Perspectives in Emergency Medicine, Critical Care Perspectives in Emergency Medicine
Epistaxis is usually straightforward—until it isn’t. How can you distinguish an anterior bleed from a dangerous posterior bleed? What’s the best sequence for compression, vasoconstrictors, TXA, cautery and packing?...
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
Severe hypermagnesemia can cause respiratory depression and heart block; IV calcium stabilizes the patient while dialysis removes magnesium when renal clearance is inadequate.
Hypermagnesaemia: Serum Mg above normal range of 1.3-2.2 mEq/L; Rare and usually iatrogenic; ↑Magnesium is closely associated with ↑K and ↓Ca
Pharmacology Corner
Two drugs for the shift
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Doxycycline
Tetracycline-class antibiotic
Indication
ED workhorse for tick-borne illness including RMSF, atypical CAP coverage, chlamydia, PID adjunct therapy, MRSA-active outpatient SSTI coverage, and some bite/wound regimens depending on local guidance.
What’s your dose? — reveal dosing & cautions
ED Dose
100 mg IV/PO once, then 100 mg q12h. Tick-borne illness/RMSF: do not delay for testing. Chlamydia: 100 mg PO q12h x 7 days.
Renal Adjustment
No renal dose adjustment.
Contraindications
Known tetracycline allergy. Avoid in pregnancy when alternatives exist; short courses in children for RMSF are recommended when clinically indicated.
Interactions
Chelation with calcium, iron, magnesium, aluminum, and bismuth; warfarin effect may increase; isotretinoin may increase intracranial hypertension risk.
Monitoring
GI intolerance, esophagitis risk, photosensitivity, adherence; counsel to take with water and avoid lying flat immediately after dosing.
ED Pearl
In suspected RMSF or severe rickettsial disease, doxycycline is a time-critical ED drug — waiting for confirmatory tests is the dangerous move.
Hypertensive emergency in selected settings, pregnancy-related severe hypertension, aortic dissection adjunct when appropriate, and neurologic BP control when heart rate/BP profile fits.
What’s your dose? — reveal dosing & cautions
ED Dose
10–20 mg IV over 2 min; repeat or double every 10 min to effect per protocol, or infusion 0.5–2 mg/min. Pregnancy severe HTN regimens often use 20/40/80 mg stepwise dosing.
Renal Adjustment
No renal adjustment; hepatic metabolism.
Contraindications
Asthma/COPD with active bronchospasm, bradycardia, heart block, cardiogenic shock, decompensated heart failure, cocaine/stimulant toxicity caution depending on scenario.
BP, HR, bronchospasm, fetal/maternal status in pregnancy, signs of heart failure.
ED Pearl
Labetalol is attractive when tachycardic hypertension needs control; it is the wrong reflex in bradycardia, bronchospasm, heart block, or crashing pump failure.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Conduction
AV Block — Third Degree / Complete Heart Block
Complete AV dissociation with an escape rhythm is a pacing problem until proven otherwise.
The Tracing
An 82-year-old man presents with weakness and near-syncope. The ECG shows P waves marching through at 80 bpm while the QRS complexes appear independently at 32 bpm. The PR intervals vary randomly because the atria and ventricles are not communicating. His blood pressure is 84/48 and he looks gray.
AV dissociation: atrial rate faster than ventricular rate with no consistent PR relationship
Regular P-P intervals and usually regular R-R intervals, but no fixed PR interval
Narrow escape rhythm suggests junctional escape; wide escape rhythm suggests ventricular escape and is less reliable
Can occur with inferior MI, anterior MI, degenerative conduction disease, hyperkalemia, medication toxicity, or post-procedure conduction injury
May be intermittent; capture a 12-lead and rhythm strip when symptoms occur
Pearls
Look for AV dissociation before calling it high-grade block. P waves hidden in T waves are the common miss.
Wide escape rhythm and hypotension should make you move quickly toward pacing.
Reversible causes matter, especially inferior MI, hyperkalemia, beta-blockers, calcium-channel blockers, and digoxin.
Pitfalls
Atropine may fail in infranodal complete heart block. Do not let repeated atropine attempts delay pacing in an unstable patient.
Transcutaneous pacing is a bridge, not definitive therapy; call cardiology early for transvenous pacing or permanent pacemaker planning.
Complete heart block can masquerade as a slow regular ventricular rhythm if you do not search for P waves.
At the Bedside
If unstable, start ACLS bradycardia management: pads on, atropine if appropriate, transcutaneous pacing, pressor infusion, and cardiology for transvenous pacing. Treat reversible causes in parallel.
For educational use only. Verify ECG interpretation against the LITFL entry and your institution’s practice before clinical decision-making.
Case of the Day
From the lead · Hypermagnesemia
Self-Examination
Test Your Understanding
A patient with advanced kidney disease becomes somnolent and bradycardic after taking magnesium-containing laxatives. She has diminished reflexes and a prolonged PR interval. What is the best immediate pharmacologic treatment?
AIV calcium gluconate
BIV potassium chloride
COral sodium polystyrene sulfonate
DIV magnesium sulfate
Reveal answer
Correct answer · A
IV calcium temporarily antagonizes magnesium’s cardiac and neuromuscular effects. It stabilizes the patient while definitive removal—often dialysis in severe toxicity with renal failure—is arranged.
Study Pace4 topics today; Issue 82 of 94 — Endocrine (Week 45 B)Deadline · June 1, 2026